Rankings
▼
Calendar
PHIO Q1 2024 Earnings — Phio Pharmaceuticals Corp. Revenue & Financial Results | Market Cap Arena
PHIO
Phio Pharmaceuticals Corp.
$13M
Q1 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$2M
Net Income
-$2M
EPS (Diluted)
$-4.24
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$2M
Free Cash Flow
-$2M
Stock-Based Comp.
$32,000
Balance Sheet
Total Assets
$7M
Total Liabilities
$1M
Stockholders' Equity
$6M
Cash & Equivalents
$6M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
-$2M
+100.0%
Operating Income
-$2M
-$4M
+38.7%
Net Income
-$2M
-$4M
+40.2%
← FY 2024
All Quarters
Q2 2024 →